Clinical significance of disordered beta-catenin expression pattern in human gastric cancers

Gastric Cancer

Volumn 3, Issue 4, 2000, Pages 193-201

  Utsunomiya, Takehiro ^a   Doki, Yuichiro ^a   Takemoto, Hiroyoshi ^a   Shiozaki, Hitoshi ^a   Yano, Masahiko ^a   Inoue, Masatoshi ^a   Yasuda, Takushi ^a   Fujiwara, Yoshiyuki ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Beta catenin; E cadherin; Gastric cancer; Immunohistochemistry; Western blot

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; FEMALE; HISTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 0034455705     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011717     Document Type: Article

References (47)

1. A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines
2. E-cadherin mediated adhesion system in cancer cells
3. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line
4. Loss of E-cadherin expression in early gastric cancer
5. Beta-catenin expression in primary and metastatic colorectal carcinoma
6. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
7. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin
8. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
9. Association of the APC gene product with beta-catenin
10. Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer
11. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers
12. Cytoplasmic beta-catenin in esophageal cancers
13. Distribution of the cadherin-catenin complex in normal human thyroid epithelium and a thyroid carcinoma cell line
14. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)
15. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation
16. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies
17. Beta-catenin expression in human cancers
18. Japanese classification of gastric carcinoma. 2nd English ed.
19. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis
20. Report of the Eleventh International Symposium of the Foundation for Promotion of Cancer Research: Basic and clinical research in gastric cancer
21. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer
22. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer
23. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
24. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer
25. Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors
26. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer
27. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
28. Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts
29. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients
30. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts
31. Analysis of the signaling activities of localization mutants of beta-catenin during axis specification in Xenopus
32. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line
33. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
34. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts
35. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium
36. Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer
37. Beta-catenin signaling can initiate feather bud development
38. Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients
39. Expression of cadherin-catenin cell adhesion molecules, phosphorylated tyrosine residues and growth factor receptor-tyrosine kinases in gastric cancers
40. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
41. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype
42. Identification of c-MYC as a target of the APC pathway
43. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
44. Matrix metalloproteinase-1 and -3 in breast cancer: Correlation with progesterone receptors and other clinicopathologic features
45. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression
46. Colorectal cancer: Molecules and populations